During the past decade, Cap José Marvá conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cap José Marvá" are "Asthma, Allergic" (2 trials), "Rhinitis, Allergic" (2 trials) and "Rhinoconjunctivitis" (2 trials). Many other conditions were trialed in "Cap José Marvá" in a lesser frequency.

Most popular intervention types in "Cap José Marvá" are "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "10,000 MG01 + 10,000 T517" (1 trials), "10,000 MG01 +10,000 T521" (1 trials), "30,000 MG01 + 10,000 T517" (1 trials), "30,000 MG01 +10,000 T521" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cap José Marvá" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cap José Marvá". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cap José Marvá, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cap José Marvá, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".